Publication: 2503

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Citation:: J Clin Oncol vol 23 (10) 2191-200

Year:: 2005
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: CA02599, CA03927, CA04326, CA04457, CA04919, CA07968, CA08025, CA11789, CA12046, CA12449, CA14028, CA16450, CA21060, CA26806, CA31809, CA31946, CA31983, CA32291, CA33601, CA35119, CA35178, CA35192, CA35279, CA37981, CA41287, CA42777, CA45377, CA45807, CA46113, CA46136, CA47559, CA47577, CA47642, CA58415, CA58416, CA58686, CA60138, CA63844, CA76447, CA76462, CA77202, CA77440, CA77651

Corr. Author:
Authors:: William P Peters Gary L Rosner James J Vredenburgh Elizabeth J Shpall Michael Crump Paul G Richardson Michael W Schuster Lawrence B Marks Constance Cirrincione Larry Norton I C Henderson Richard L Schilsky David D Hurd

Networks:

Study: CALGB-9082
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Carmustine, Chemotherapy, Adjuvant, Cisplatin, Cyclophosphamide, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Granulocyte Colony-Stimulating Factor, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Peripheral Blood Stem Cell Transplantation, Prognosis, Prospective Studies, Risk Factors, Treatment Outcome